Article info

Download PDFPDF
036
AUTOANTIBODIES IN GLIOMA PATIENTS: IMMUNE BIOMARKERS FOR IDENTIFICATION OF LOW GRADE TUMOURS

Authors

  • James Coleman Department of Clinical Neurology, Queen's Medical Centre, Nottingham; Centre of Excellence for Autoimmunity in Cancer, University of Nottingham PubMed articlesGoogle scholar articles
  • Saam Sedehizadeh Department of Clinical Neurology, Queen's Medical Centre, Nottingham; Centre of Excellence for Autoimmunity in Cancer, University of Nottingham PubMed articlesGoogle scholar articles
  • Caroline Chapman Department of Clinical Neurology, Queen's Medical Centre, Nottingham; Centre of Excellence for Autoimmunity in Cancer, University of Nottingham PubMed articlesGoogle scholar articles
  • Rachelle Shafei Department of Clinical Neurology, Queen's Medical Centre, Nottingham; Centre of Excellence for Autoimmunity in Cancer, University of Nottingham PubMed articlesGoogle scholar articles
  • Alison Thorpe Department of Clinical Neurology, Queen's Medical Centre, Nottingham; Centre of Excellence for Autoimmunity in Cancer, University of Nottingham PubMed articlesGoogle scholar articles
  • John Robertson Department of Clinical Neurology, Queen's Medical Centre, Nottingham; Centre of Excellence for Autoimmunity in Cancer, University of Nottingham PubMed articlesGoogle scholar articles
  • Paul Maddison Department of Clinical Neurology, Queen's Medical Centre, Nottingham; Centre of Excellence for Autoimmunity in Cancer, University of Nottingham PubMed articlesGoogle scholar articles

    Citation

    Coleman J, Sedehizadeh S, Chapman C, et al
    AUTOANTIBODIES IN GLIOMA PATIENTS: IMMUNE BIOMARKERS FOR IDENTIFICATION OF LOW GRADE TUMOURS

    Publication history

    • First published October 9, 2013.
    Online issue publication 
    October 09, 2013

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.